Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04938817
Title Safety and Efficacy Study of Pembrolizumab (MK-3475) in Combination With Investigational Agents for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Age Groups: adult | senior
Covered Countries USA | ITA | ESP | CAN | AUT | AUS

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center ( Site 0152) Gilbert Arizona 85234 United States Details
Georgia Cancer Specialists ( Site 0156) Atlanta Georgia 30341 United States Details
Parkview Research Center at Parkview Regional Medical Center ( Site 0180) Fort Wayne Indiana 46845 United States Details
Baptist Health Lexington-Research ( Site 0158) Lexington Kentucky 40503 United States Details
University of Kentucky Chandler Medical Center-Medical Oncology ( Site 0157) Lexington Kentucky 40536 United States Details
MFSMC-HJWCI-Oncology Research ( Site 0178) Baltimore Maryland 21237 United States Details
Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0172) Omaha Nebraska 68130 United States Details
Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0179) Omaha Nebraska 68130 United States Details
Cleveland Clinic-Taussig Cancer Center ( Site 0166) Cleveland Ohio 44195 United States Details
UPMC Hillman Cancer Center ( Site 0177) Pittsburgh Pennsylvania 15232 United States Details
St Francis Cancer Center-Research Office ( Site 0167) Greenville South Carolina 29607 United States Details
Virginia Cancer Institute ( Site 0169) Richmond Virginia 23229 United States Details
Westmead Hospital-Department of Medical Oncology ( Site 4004) Westmead New South Wales 2145 Australia Details
The Prince Charles Hospital-Oncology Clinical Trials ( Site 4003) Brisbane Queensland 4032 Australia Details
Monash Health-Oncology Research ( Site 4005) Clayton Victoria 3168 Australia Details
Hollywood Private Hospital-Medical Oncology ( Site 4001) Perth Western Australia 6009 Australia Details
Klinik Penzing-2. Lungenabteilung ( Site 3101) Vienna Wien 1140 Austria Details
Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 3100) Wien 1210 Austria Details
Cross Cancer Institute ( Site 3004) Edmonton Alberta T6G 1Z2 Canada Details
Princess Margaret Cancer Centre ( Site 3003) Toronto Ontario M5G 2M9 Canada Details
St. Marys Hospital Center ( Site 3000) Montreal Quebec H3T 1M5 Canada Details
Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház-Onkologiai Kozpont ( Site 3800) Szolnok Jasz-Nagykun-Szolnok 5004 Hungary Details
Rambam Health Care Campus-Oncology ( Site 3600) Haifa 3109601 Israel Details
Shaare Zedek Medical Center-Oncology ( Site 3602) Jerusalem 9103102 Israel Details
Meir Medical Center ( Site 3601) Kfar Saba 4428164 Israel Details
Rabin Medical Center-Oncology ( Site 3604) Petah Tikva 4941492 Israel Details
Sheba Medical Center-ONCOLOGY ( Site 3603) Ramat Gan 5265601 Israel Details
Ospedale San Raffaele-Oncologia Medica ( Site 3303) Milano Lombardia 20132 Italy Details
Humanitas-U.O di Oncologia medica ed Ematologia ( Site 3301) Rozzano Milano 20089 Italy Details
ospedale le scotte-U.O.C. Immunoterapia Oncologica ( Site 3300) Siena Toscana 53100 Italy Details
Istituto Europeo di Oncologia IRCCS-Divisione di Oncologia Toracica ( Site 3304) Milano 20141 Italy Details
Chungbuk National University Hospital ( Site 4106) Cheongju-si Chungbuk 28644 Korea, Republic of Details
Seoul National University Bundang Hospital-Medical Oncology ( Site 4104) Seongnam Kyonggi-do 13620 Korea, Republic of Details
Seoul National University Hospital ( Site 4101) Seoul 03080 Korea, Republic of Details
Asan Medical Center-Lung Cancer Center ( Site 4103) Seoul 05505 Korea, Republic of Details
Samsung Medical Center ( Site 4100) Seoul 06351 Korea, Republic of Details
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier Warszawa Mazowieckie 02-781 Poland Details
Samodzielny Publiczny Zespó Grulicy i Chorób Puc w Olsztynie-Oddzial Onkologii z Pododdzialem Chemi Olsztyn Warminsko-mazurskie 10-357 Poland Details
Krasnoyarsk Regional Oncology Dispensary, Named after Krizhanovsky ( Site 3708) Krasnoyarsk Krasnoyarskiy Kray 660133 Russian Federation Details
Saint-Petersburg City Clinical Oncology Dispensary-Department of chemotherapy ( Site 3702) Saint Petersburg Leningradskaya Oblast 198255 Russian Federation Details
N.N.Petrov Research Institute of Oncology-Department of Chemotherapy and Innovative Technologies ( S Saint Petersburg Sankt-Peterburg 197758 Russian Federation Details
GBUZ LOKB-Oncology department #1 ( Site 3701) Saint-Petersburg Sankt-Peterburg 194291 Russian Federation Details
GBUZ "SPb CRPCstmc(o)" ( Site 3705) Saint-Petersburg Sankt-Peterburg 197758 Russian Federation Details
Scientific research institution of oncology named after N.N. Petrov-Thoracic oncology ( Site 3704) Sankt-Peterburg 197758 Russian Federation Details
Instituto Catalan de Oncologia - Hospital Duran i Reynals ( Site 3403) L'Hospitalet de Llobregat Cataluna 08908 Spain Details
Hospital Universitari Vall d'Hebron-Oncology ( Site 3401) Barcelona 08035 Spain Details
Cantonal Hospital St.Gallen-Oncology & Hematology ( Site 3502) st.Gallen Sankt Gallen 9007 Switzerland Details
*Shaded cells indicate that there was no data available from for the field